{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:03:37Z","timestamp":1792602217522,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01-DA48876"],"award-info":[{"award-number":["R01-DA48876"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.josat.2023.209051","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T11:51:32Z","timestamp":1681905092000},"page":"209051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians"],"prefix":"10.1016","volume":"149","author":[{"given":"Marisa D.","family":"Booty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathi","family":"Harp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Batty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah K.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Staton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie B.","family":"Oser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209051_bb0005","series-title":"Over-jailed and un-treated: How the failure to provide treatment for substance use in prisons and jails fuels the overdose epidemic","year":"2021"},{"key":"10.1016\/j.josat.2023.209051_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugpo.2017.11.021","article-title":"A qualitative study comparing physician reported barriers to treating addiction using buprenorphine and extended-release naltrexone in US office-based practices","volume":"54","author":"Andraka-Christou","year":"2018","journal-title":"International Journal of Drug Policy"},{"issue":"9","key":"10.1016\/j.josat.2023.209051_bb0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.josat.2023.209051_bb0020","series-title":"Shaping justice for the future","article-title":"More work to do: Analysis of probation and parole in the United States, 2017-2018","author":"Bradner","year":"2020"},{"key":"10.1016\/j.josat.2023.209051_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugalcdep.2017.11.023","article-title":"A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release","volume":"184","author":"Brinkley-Rubinstein","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.josat.2023.209051_bb0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1037\/0003-066X.32.7.513","article-title":"Toward an experimental ecology of human development","volume":"32","author":"Bronfenbrenner","year":"1977","journal-title":"American Psychologist"},{"issue":"1","key":"10.1016\/j.josat.2023.209051_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13722-018-0124-2","article-title":"Clinician identified barriers to treatment for individuals in appalachia with opioid use disorder following release from prison: A social ecological approach","volume":"13","author":"Bunting","year":"2018","journal-title":"Addiction Science & Clinical Practice"},{"issue":"7","key":"10.1016\/j.josat.2023.209051_bb0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0020764020985891","article-title":"Health care providers and people with mental illness: An integrative review on anti-stigma interventions","volume":"67","author":"Carrara","year":"2021","journal-title":"International Journal of Social Psychiatry"},{"key":"10.1016\/j.josat.2023.209051_bb0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jsat.2015.05.001","article-title":"Risk factors for relapse and higher costs among medicaid members with opioid dependence or abuse: Opioid agonists, comorbidities, and treatment history","volume":"57","author":"Clark","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209051_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102701","article-title":"Buprenorphine dispensing in an epicenter of the US opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky","volume":"85","author":"Cooper","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209051_bb0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11469-012-9402-5","article-title":"Drug addiction stigma in the context of methadone maintenance therapy: An investigation into understudied sources of stigma","volume":"11","author":"Earnshaw","year":"2013","journal-title":"International Journal of Mental Health and Addiction"},{"issue":"1","key":"10.1016\/j.josat.2023.209051_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2023.209051_bb0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2014.10.001","article-title":"Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections","volume":"50","author":"Friedmann","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209051_bb0070","series-title":"For better results, cut correctional populations","author":"Gelb","year":"2017"},{"key":"10.1016\/j.josat.2023.209051_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102768","article-title":"A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system","volume":"81","author":"Grella","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209051_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13011-021-00346-1","article-title":"A scoping review of factors that influence opioid overdose prevention for justice-involved populations","volume":"16","author":"Grella","year":"2021","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"4","key":"10.1016\/j.josat.2023.209051_bb0085","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/add.13238","article-title":"Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial","volume":"111","author":"Hser","year":"2016","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.josat.2023.209051_bb0090","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qualitative Health Research"},{"key":"10.1016\/j.josat.2023.209051_bb0095","series-title":"CLA and JCOIN course: Implementing medications for addiction treatment (MAT) in correctional settings","year":"2022"},{"issue":"3","key":"10.1016\/j.josat.2023.209051_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.josat.2023.209051_bb0105","series-title":"Health disparities in Appalachia: Health care systems","first-page":"215","author":"Marshall","year":"2017"},{"issue":"4","key":"10.1016\/j.josat.2023.209051_bb0110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/109019818801500401","article-title":"An ecological perspective on health promotion programs","volume":"15","author":"McLeroy","year":"1988","journal-title":"Health Education Quarterly"},{"issue":"1","key":"10.1016\/j.josat.2023.209051_bb0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/08897077.2015.1129389","article-title":"Community correctional agents\u2019 views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices","volume":"37","author":"Mitchell","year":"2016","journal-title":"Substance Abuse"},{"issue":"3","key":"10.1016\/j.josat.2023.209051_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066068","article-title":"Social ecological factors and medication treatment for opioid use disorder among justice-involved rural and urban persons: The geographic variation in addiction treatment experiences (GATE) longitudinal cohort study protocol","volume":"13","author":"Oser","year":"2023","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.josat.2023.209051_bb0125","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2105\/AJPH.2018.304514","article-title":"Opioid overdose mortality among former North Carolina inmates: 2000\u20132015","volume":"108","author":"Ranapurwala","year":"2018","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2023.209051_bb0130","first-page":"113","article-title":"Using the Americans with disabilities act to reduce overdose deaths","volume":"70","author":"Sinkman","year":"2022","journal-title":"Department of Justice Journal of Federal Law and Practice"},{"key":"10.1016\/j.josat.2023.209051_bb0135","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.josat.2023.209051_bb0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5055\/jom.2008.0012","article-title":"A pilot survey of attitudes and knowledge about opioid substitution therapy for HIV-infected prisoners","volume":"4","author":"Springer","year":"2008","journal-title":"Journal of Opioid Management"},{"issue":"14","key":"10.1016\/j.josat.2023.209051_bb0145","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1080\/10826084.2018.1482346","article-title":"Intent to refer: Exploring bias toward specific medication-assisted treatments by community corrections employees","volume":"53","author":"Streisel","year":"2018","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2023.209051_bb0150","article-title":"Substance Abuse and Mental Health Services Administration: Use of medication-assisted treatment for opioid use disorder in criminal justice settings","year":"2019"},{"issue":"3","key":"10.1016\/j.josat.2023.209051_bb0155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","article-title":"County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States","volume":"73","author":"Van Handel","year":"2016","journal-title":"Journal of Acquired Immune Deficiency Syndromes (1999)"},{"issue":"2","key":"10.1016\/j.josat.2023.209051_bb0160","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:39Z","timestamp":1762652379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":32,"alternative-id":["S2949875923001017"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209051","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209051"}}